Metropolitan Life Insurance Company (MetLife)’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,150
| Closed | -$98.8K | – | 1810 |
|
|
2024
Q1 | $98.8K | Buy |
4,150
+343
| +9% | +$8.16K | ﹤0.01% | 1056 |
|
|
2023
Q4 | $82.3K | Hold |
3,807
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q3 | $55.3K | Buy |
3,807
+205
| +6% | +$2.98K | ﹤0.01% | 1349 |
|
|
2023
Q2 | $75.4K | Buy |
3,602
+348
| +11% | +$7.28K | ﹤0.01% | 1179 |
|
|
2023
Q1 | $68.7K | Sell |
3,254
-37
| -1% | -$781 | ﹤0.01% | 1204 |
|
|
2022
Q4 | $83.8K | Buy |
3,291
+210
| +7% | +$5.35K | ﹤0.01% | 1156 |
|
|
2022
Q3 | $74K | Hold |
3,081
| – | – | ﹤0.01% | 1200 |
|
|
2022
Q2 | $59.3K | Hold |
3,081
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q1 | $53.5K | Sell |
3,081
-9,976
| -76% | -$173K | ﹤0.01% | 1556 |
|
|
2021
Q4 | $286K | Hold |
13,057
| – | – | ﹤0.01% | 1768 |
|
|
2021
Q3 | $250K | Hold |
13,057
| – | – | ﹤0.01% | 1910 |
|
|
2021
Q2 | $224K | Buy |
13,057
+5,127
| +65% | +$88K | ﹤0.01% | 2060 |
|
|
2021
Q1 | $177K | Hold |
7,930
| – | – | ﹤0.01% | 2101 |
|
|
2020
Q4 | $176K | Hold |
7,930
| – | – | ﹤0.01% | 2015 |
|
|
2020
Q3 | $117K | Hold |
7,930
| – | – | ﹤0.01% | 2129 |
|
|
2020
Q2 | $118K | Hold |
7,930
| – | – | ﹤0.01% | 2152 |
|
|
2020
Q1 | $87K | Buy |
+7,930
| New | +$87K | ﹤0.01% | 2115 |
|